Publications by authors named "Jose-Angel Hernandez-Rivas"

Claim this Profile
A
A First-In-Human Study of the SUMOylation Inhibitor Subasumstat in Patients with Advanced/Metastatic Solid Tumors or Relapsed/Refractory Hematologic Malignancies.
Dejan Juric, Daniel Anderson, Afshin Dowlati, Jordi Rodon, Iwona Lugowska

Cancer Res Commun· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors Increasing the Risk of Infection in Patients With Multiple Myeloma: From Biology to Prevention.
Cristina Encinas, Maria Jesús Blanchard, Rafael Alonso Fernández, José-Ángel Hernández-Rivas, Rafael Ríos Tamayo

Clin Lymphoma Myeloma Leuk· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overall survival outcomes with first-line continuous ibrutinib and fixed-duration ibrutinib-venetoclax treatments in patients with chronic lymphocytic leukemia: Comparison with an age-matched European population.
Paolo Ghia, Loic Ysebaert, Ann Janssens, Stephan Stilgenbauer, Mohamed Fouad

Hemasphere· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Co-infections during SARS-CoV-2 infection in hematologic patients and cell therapy recipients in the omicron era: a Spanish hematopoietic stem cell transplantation and cell therapy group study.
Pedro Chorão, Alex Avendaño, Inmaculada Heras, Francesco Aiello, Mireia Micó-Cerdá

BMC Infect Dis· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia and small lymphocytic lymphoma from Chronic Lymphocytic Leukemia Spanish Group (GELLC).
Ángeles Medina, Ana Muntañola, Marta Crespo, Ángel Ramírez, José-Ángel Hernández-Rivas

Med Clin (Barc)· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editorial: Elderly patients and lymphoma.
Maria S Infante, José-Angel Hernández-Rivas

Front Oncol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunoparesis recovery in newly diagnosed transplant ineligible multiple myeloma patients, an independent prognostic factor that complements minimal residual disease.
Sunil Lakhwani, María Victoria Mateos, Joaquín Martínez-López, Bruno Paiva, Laura Rosiñol Dachs

Ann Hematol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Evidence on Adverse Events and Healthcare Resource Utilization in Patients with Chronic Lymphocytic Leukaemia in Spain Using Natural Language Processing: The SRealCLL Study.
Pau Abrisqueta-Costa, José Antonio García-Marco, Antonio Gutiérrez, José Ángel Hernández-Rivas, Rafael Andreu-Lapiedra

Cancers (Basel)· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Iron deficiency anemia: an early clinical presentation of cytomegalovirus-induced hemorrhagic colitis in chronic myeloid leukemia patients under dasatinib treatment.
Laura Sanchez-Paz, Pernilla Seidi Tirado Zambrana, Carlos Villa Poza, José-Ángel Hernández-Rivas, Elena Landete Hernández

Ther Adv Hematol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chronic lymphocytic leukemia patients with chromosome 6q deletion as the sole cytogenetic abnormality display a high frequency of RPS15 mutations and have a poor prognosis.
Claudia Pérez Carretero, Teresa González, Miguel Quijada Álamo, Gian Matteo Rigolin, Adrian Dubuc

Am J Hematol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low dose lenalidomide versus placebo in non-transfusion dependent patients with low risk, del(5q) myelodysplastic syndromes (SintraREV): a randomised, double-blind, phase 3 trial.
María Díez-Campelo, Félix López-Cadenas, Blanca Xicoy, Eva Lumbreras, Teresa González

Lancet Haematol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic strategies and treatment sequencing in patients with chronic lymphocytic leukemia: An international study of ERIC, the European Research Initiative on CLL.
Thomas Chatzikonstantinou, Lydia Scarfò, Eva Minga, Georgios Karakatsoulis, Dimitra Chamou

Hemasphere· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dexamethasone treatment for COVID-19 is related to increased mortality in hematologic malignancy patients: results from the EPICOVIDEHA registry.
Tommaso Francesco Aiello, Jon Salmanton-Garcia, Francesco Marchesi, Barbora Weinbergerova, Andreas Glenthoj, Jose-Angel Hernandez-Rivas

Haematologica· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Ibrutinib followed by ofatumumab consolidation in previously untreated patients with chronic lymphocytic leukemia (CLL): GELLC-7 trial from the Spanish group of CLL (GELLC).
Pau Abrisqueta, Eva González-Barca, Christelle Ferrà, Eduardo Ríos-Herranz, Margarita Fernández de la Mata

EClinicalMedicine· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune response against the SARS-CoV-2 spike protein in cancer patients after COVID-19 vaccination during the Omicron wave: a prospective study.
María José Muñoz-Gómez, Pablo Ryan, Marta Quero-Delgado, María Martin-Vicente, Guillermo Cuevas

J Infect Public Health· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Omicron SARS-CoV-2 infection management and outcomes in patients with hematologic disease and recipients of cell therapy.
José Luis Piñana, Lourdes Vazquez, Inmaculada Heras, Tommaso Francesco Aiello, Lucia López-Corral

Front Oncol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Decoding the historical tale: COVID-19 impact on haematological malignancy patients-EPICOVIDEHA insights from 2020 to 2022.
Jon Salmanton-García, Francesco Marchesi, Francesca Farina, Barbora Weinbergerová, Federico Itri

EClinicalMedicine· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: Detection of kinase domain mutations in BCR::ABL1 leukemia by ultra-deep sequencing of genomic DNA.
Ricardo Sánchez, Sara Dorado, Yanira Ruíz-Heredia, Alejandro Martín-Muñoz, Juan Manuel Rosa-Rosa

Sci Rep· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COVID-19 Outcomes in Patients with Hematologic Malignancies in the Era of COVID-19 Vaccination and the Omicron Variant.
Joaquín Martínez-López, Javier de la Cruz, Rodrigo Gil-Manso, Víctor Jiménez Yuste, José María Aspa-Cilleruelo

Cancers (Basel)· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of Cytogenetics Aberrations and Mutations with Outcome in Chronic Lymphocytic Leukemia Patients in a Real-World Clinical Setting.
Carolina Muñoz-Novas, Isabel González-Gascón-Y-Marín, Iñigo Figueroa, Laura Sánchez-Paz, Claudia Pérez-Carretero

Glob Med Genet· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The evolving landscape of COVID-19 and post-COVID condition in patients with chronic lymphocytic leukemia: A study by ERIC, the European research initiative on CLL.
Andrea Visentin, Thomas Chatzikonstantinou, Lydia Scarfò, Anargyros Kapetanakis, Christos Demosthenous

Am J Hematol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Challenging Diagnosis of Invasive Sinus Aspergillosis Mimicking Gradenigo's Syndrome in an Elderly Patient with T-Cell Lymphoma.
Victoria Ramos de Ascanio, Gloria Liaño-Esteso, David Roldán, Teresa Collazo-Lorduy, Sara Martínez-Flores

Geriatrics (Basel)· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Other malignancies in the history of CLL: an international multicenter study conducted by ERIC, the European Research Initiative on CLL, in HARMONY.
Thomas Chatzikonstantinou, Lydia Scarfò, Georgios Karakatsoulis, Eva Minga, Dimitra Chamou

EClinicalMedicine· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Remdesivir or Nirmatrelvir/Ritonavir Therapy for Omicron SARS-CoV-2 Infection in Hematological Patients and Cell Therapy Recipients.
José Luis Piñana, Inmaculada Heras, Tommaso Francesco Aiello, Irene García-Cadenas, Lourdes Vazquez

Viruses· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Five "Ws" of Frailty Assessment and Chronic Lymphocytic Leukemia: Who, What, Where, Why, and When.
Isabel González-Gascón-Y-Marín, Mónica Ballesteros-Andrés, Sara Martínez-Flores, Ana-E Rodríguez-Vicente, Claudia Pérez-Carretero

Cancers (Basel)· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis